Authors: Robyn E O'Hehir; David Price; Phil Lieberman; Dermot Ryan; Magnus Wickman; Claus Bachert; Jan Brozek; Jean Bousquet; Davide Caimmi; João Fonseca; Erkka Valovirta; W. Carr; Gérard Dray; Karl Christian Bergmann; Arzu Yorgancioglu; Anne Lise Courbis; Massimo Triggiani; Ruth Murray; Ioana Agache; Désirée Larenas Linnemann; Tari Haahtela; Peter Valentin Tomazic; Paulo Augusto Moreira Camargos; Nikolaos G. Papadopoulos; Michiel van Eerd; Martin Wagenmann; Anna Bedbrook; Caterina Bucca; Mário Morais-Almeida; Arunas Valiulis; Bolesław Samoliński; Govert De Vries; Joaquim Mullol; Giorgio Walter Canonica; Thomas B. Casale; Sylvie Arnavielhe; Sinthia Bosnic-Anticevich; Ludger Klimek; F. Estelle R. Simons; Omer Kalayci; Piotr Kuna; Violeta Kvedariene

Venue: Clinical & Experimental Allergy

Type: Publication

Abstract: SummaryBackgroundAllergic rhinitis (AR) management has changed in recent years following the switch from the concept of disease severity to the concept of disease control, publication of the AR clinical decision support system (CDSS) and development of mobile health (m‐health) tools for patients (eg Allergy Diary). The Allergy Diary Companion app for healthcare providers is currently being developed and will be launched in 2018. It incorporates the AR CDSS to provide evidence‐based treatment recommendations, linking all key stakeholders in ... (read more)

DOI: 10.1111/cea.13230